Group items tagged

NHS England's decision to forgo commissioning puberty suppressing hormones (PSH) for children and young people, citing insufficient evidence of their safety and clinical effectiveness, follows a comprehensive review conducted by the National Institute for Health and Care Excellence (NICE) in 2020. The clinical report underscores that "PSH treatment options will not be part of routine commissioning" for people under the age of 18 in England grappling with gender incongruence or dysphoria. The NHS England review analysed nine observational studies on Gonadotrophin Releasing Hormone Analogues (GnRHa) and found no statistically significant difference in gender dysphoria, mental health, body image, and psychosocial functioning among children and adolescents treated with GnRHa. Duncan Rudkin, chief executive of the General Pharmaceutical Council (GPhC), acknowledged the challenges faced by pharmacy professionals regarding prescriptions for puberty suppressing hormones, stating:

Register for upcoming Emergency Medicine Conferences, Online CME Courses, Live Webinars, In-person Medical Conferences & Hybrid Events in 2024. Explore all the Emergency Medicine CME/CE conferences and online courses hosted by renowned medical experts and institutions.

Cancer patients in the UK are being given a new immunotherapy treatment at Imperial College Healthcare NHS Trust as part of a global phase 1/2 clinical trial, which aims to evaluate its safety and potential for treating 'solid tumour' cancers such as melanoma and lung cancer. The experimental therapy, called mRNA-4359, has been designed to train patients' immune systems to recognise and fight cancer cells, according to researchers at Imperial College London. For the first time in the UK, cancer patients received the treatment at the National Institute for Health and Care Research (NIHR) Imperial Clinical Research Facility at Hammersmith Hospital. In this non-randomised trial, mRNA-4359 is administered to patients either alone or in combination with an existing cancer drug called pembrolizumab, a type of immune checkpoint inhibitor. The researchers are hopeful that this new therapeutic approach, if proven to be safe and effective in clinical trials, could lead to a new treatment option for difficult-to-treat cancers.

After receiving approval from the National Institute for Health and Care Excellence (NICE), the NHS is preparing to roll out a new combination treatment for brain tumours in children and young people in England. Dabrafenib with trametinib would be the first ever targeted treatment for children (aged 1-17) with gliomas that have a specific genetic mutation, the health service said. The treatment, which can be taken at home, has been found to slow the progression of the disease by over threefold compared to standard chemotherapy in children with low-grade gliomas that have a BRAF V600E mutation. Clinical trials have shown that it causes fewer side-effects than chemotherapy. NICE approved the combination treatment on Wednesday 24 April. It will be available on the NHS in the coming months.

Patients want to be active partners in their healthcare decisions - and eye care is no exception. Patient education is vital for understanding diagnoses, treatment options, and the importance of preventative care. When patients understand what's happening with their health, they're far more likely to follow their treatment plan and see good results. Here's a deeper look at why patient education matters. Patient-Centered Care: The Key to Success The Institute of Medicine emphasizes the importance of patient-centered care. This means involving patients in decision-making and providing them with the necessary education for informed choices. This approach is even more crucial in eye care, where conditions can lead to irreversible blindness. The Need for Patient Education Research shows that many patients crave educational materials from their eye care providers, but many don't receive them. This leaves patients searching for information on their own, potentially turning to unreliable sources. Clear, accessible patient education is vital in ensuring understanding and treatment adherence.For instance, patient education is crucial in preventing diseases like glaucoma. The more informed patients are, the more chances they will discover early signs of disease by taking OCT test for glaucoma.

The National Health Services England (NHSE) is poised to revolutionise diabetes management with the introduction of the 'artificial pancreas', also known as the Hybrid Closed Loop system, to treat type 1 diabetes. This pioneering initiative, endorsed by the National Institute of Health Care and Excellence (NICE), represents a global first in healthcare innovation. With 269,095 individuals grappling with type 1 diabetes in England, the Hybrid Closed Loop system is set to cater to tens of thousands of children and adults across the nation. This cutting-edge device operates by seamlessly monitoring blood glucose levels and autonomously adjusting insulin dosage through a pump, by eliminating the need for regular insulin injections. Furthermore, it holds the promise of averting life-threatening hypoglycaemic and hyperglycaemia episodes, mitigating significant risks associated with the condition. To facilitate the identification of beneficiaries, NHSE has allocated a substantial sum of £2.5 million, ensuring that those who could benefit from this innovative solution receive the necessary support.

Patients suffering from chronic and episodic migraine attacks are set to benefit from a groundbreaking recommendation by the National Institute for Health and Care Excellence (NICE) regarding a new medication. The atogepant, a first-of-its-kind preventive drug for migraine, offers hope for those grappling with this debilitating condition and can be taken orally. Published as part of the final guidance draft, NICE has greenlit the atogepant, also known as Aquipta and manufactured by AbbVie, as an option for preventing both chronic and episodic migraines in adults. Specifically, this recommendation is for individuals who have experienced at least four migraine days per month and have failed to find relief with at least three previous preventive treatments. With approximately 4.5 million people in the UK affected by various forms of migraine, this new recommendation marks a significant advancement in migraine management as the condition significantly impacts patients' day-to-day activities as well as places a heavy burden on the NHS and the wider economy.

The NHS England last week released a survey report on the involvement of pharmacy professionals in research, and proposed the implementation of a clinical academic training pathway for pharmacy professionals by 2030. Recommendations were made to support the embedding of research at all stages of a pharmacy professional's career. The report presented the findings of two surveys that NHS England launched in May 2022, one for individual pharmacy professionals and one for organisations, calling for evidence on clinical academic careers in pharmacy. The survey found that only a minority of the pharmacy workforce take up clinical research training opportunities. "Just under a quarter of individual respondents had applied for the National Institute of Health and Care Research (NIHR) or other research project grants, and just under half of the organisational survey respondents had supported individuals to apply for such a grant," it said.

The only way to overcome the challenges facing the medicines supply chain in the UK is through close cooperation - the government, pharmacies, and the industry all working together in tandem - said Andrew Stephenson, Minister for Health and Social Care. The MP for Pendle, Lancashire made the statement while addressing the Healthcare Distribution Association's (HDA) Annual Conference at the Institute of Directors in Pall Mall, London on Thursday (25 January), where over 130 leaders from the pharma industry gathered. As the keynote speaker, Stephenson acknowledged the crucial role wholesalers, manufacturers, and retail pharmacy chains, play in the wellbeing of the nation. He said: "In the first few months that I've been in this job, it's become immediately obvious to me just how important this sector is and just how important the work that all of you do is for our country."

Researchers from the London School of Hygiene & Tropical Medicine (LSHTM) have been tasked to evaluate the impact, safety and effectiveness of the Pharmacy First service, which was launched across England in January 2024. They have been awarded £2.4million by the National Institute for Health and Care Research (NIHR) to generate evidence on the new service that allows pharmacies to provide advice and treatment for seven common conditions without the need for a GP appointment. After consultation, if necessary, a community pharmacist can supply some prescription-only medicines to treat earache, sore throat, sinusitis, impetigo, shingles, infected insect bites or uncomplicated urinary tract infections in women. The LSHTM researcher team will be working together with experts at the UK Health Security Agency (UKHSA) and the Universities of Oxford, Manchester and Nottingham on the project. Dr Rebecca Glover, assistant professor in Antimicrobial Resistance at LSHTM, who will lead the three-year project, said they will evaluate "Pharmacy First's impact on GPs and the wider NHS, pharmacy services and patients."

Staveley Pharmacy, a well-established community pharmacy located in the picturesque village of Kendal within the Lake District, has undergone a change in ownership. The family-run business led by a husband-and-wife team has been acquired by brothers Mohammad Waqas and Khuram Shazad, taking the helm as first-time buyers, according to Hutchings Consultants. Known for its strong counter trade and deep community ties, the pharmacy has been nurtured and managed by the previous owners with a profound dedication to the local community. Over the years, they have developed the business into a trusted local institution. Paul Steet, Associate Director of Hutchings who managed the sale, reflected on the transition, noting the longstanding relationship with the sellers. "Having worked with the previous owners since 2015 when they initially contacted Hutchings Consultants to discuss a valuation of the business, I feel personally connected to this pharmacy. I am delighted that Mohammad and Khuram will be taking over the reins," he said.

If you are looking for a clinic that provides treatment for Arm Lift Tampa, then The Julian Institute of Plastic Surgery is an ideal choice for you. Its surgeons are quite well versed in their job to offer efficient treatment to you.

Hyderabad: The doctors at the All India Institute of Medical Sciences (AIIMS) in Delhi have clarified that a surgery for separation of conjoined twins Veena and Vani would involve high risk. Doctors told that in separating conjoined twins Veena and Vani there are chances that they can become comatose and saving their life on operation table may be difficult.

Tynor Wrist Splint with Thumb Applications Wrist and Thumb injuries. Injuries of the metacarpal. Early cast removal. Fracture management. Post-surgical protection and rehabilitation. Management of arthritic conditions of the wrist. Bursitis, Tendonitis, Tensosynovitis. Psychological assurance. Post extensor tendon repair surgery. Tynor Wrist Splint with Thumb Features Customizable Splints. Anatomical thumb abduction. Fits both left and right hand. Lace pull mechanism for easy application. Pleasing aesthetics. Tynor Wrist Splint with Thumb Measurements Measure circumference at a distance 6" from the wrist along the arm

A new sense a hope rises from Washington. Researchers have finally come up with a significant discovery that could probably lead us to a way for a new treatment for Parkinson's disease.

Michael Mullan Ph.D., M.D, CEO, Roskamp Institute, United States,Michael Mullan is a biomedical researcher of the beta amyloid protein and its relation to Alzheimer

US-based biotech startup DesignMedix has received a grant of $3m from the National Institutes of Health (NIH) to continue the development and manufacturing of a new anti-malarial drug.

E-Learning industry is witnessing tremendous growth in terms of revenue and application. It has become a synonym for many of the learning requirements in corporates, academics and government institutions. To provide most suitable learning solutions, industry experts exploring and inventing creative methods and approaches such as Custom Learning Solutions, Rapid Learning Solutions, Gamifications, Instructor Led Training programs and blend of these methods and approaches.

Standard Wheelchair are the most frequently used wheelchair. Standard wheelchair weigh over 35 pounds. without the front riggings, have a seat width and depth between 16 and 20 inches, and have fixed or detachable armrests. Almost all standard wheelchairs can support up to 250 pounds.This very functionally designed, folding, stainless steel wheelchair is fitted with removable armrests and swingaway detachable footrests.They also can be bought with various wheelchair accessories such as attendant brakes. Hip Width: Use this to figure seat width if it is the widest point. Chest Width: Measure the widest point of the thorax just below the arm pit. This measurement may influence system width or back width. Heel to Knee: Use this for legrest extensions and seat height. Shoulder Height: This will determine the height and the style of the back panel or the start for a custom back. Head Height: This will help determine the proper headrest height. Features- Supplied with swingaway removable legrests, calf strap and removable armrests Folding frame for easy storage and transportation Breathable padded nylon upholstery (vinyl upholstery option available) Rear backrest upholstery storage pocket

Standard Manual Wheelchairs are the most commonly used type of wheelchair, if searching for a standard wheelchair with a durable frame and long-lasting support, take a look at standard wheelchairs. The Standard Wheelchair usually weighs over 35 lbs, have a seat width between 16 and 20 inches, and feature fixed or detachable armrests. Most are made with steel frames and can be an economical and consistent mobility choice. Almost all standard wheelchairs can support up to 250 lb. A standard wheelchair is designed to support longer trips, and to allow for self propulsion. These chairs almost always feature two, large, rear-mounted wheels that the user can set in motion by hand, so if need to be able to operate chair without aid from a loved one or caregiver, a standard wheelchair is an ideal option. Storage is a breeze with these units as well and every model we carry is foldable, allowing the user to fit his/her chair into a tighter spaces. Standard Wheelchairs, also known as Power Operated Vehicles (POVs), are a good choice if need assistance getting around home or apartment and don't have advanced seating or positioning needs. The right Standard Wheelchair will allow to get around home with ease and without getting tired. A Standard Wheelchair allows to go where it need, when it need, with little to no assistance. Numotion will work with it and clinicians to see if a Standard Wheelchair is the right choice. Features: Good for travel and in large outdoor spaces. Designed for mobility on the go. Easy control. Adjust for speed and comfort. Conveniently charged by simply plugging in.

4 Wheel Wheelchair With 4 Small Wheels foldable frame wheelchair made of chrome with 18" inches seatwidth, 8" Inches Front and Rear wheel, total weight 14 kg helps physical challenged person to move around indoor. Features- Wheelchair With 4 Small Wheels Features Foldable Wheelchair 4 Small Wheels Wheelchair frame made of chrome Waterproof wheelchair

A wheelchair is a wheeled mobility device in which the user sits. The device is propelled either manually (by turning the wheels by the hand) or via various automated systems. Wheelchairs are used by people for whom walking is difficult or impossible due to illness (physiological or physical), injury, or disability. The chair seat size (width and depth), seat-to-floor height, footrests/leg rests, front caster outriggers, adjustable backrests, controls, and many other features can be customized on, or added to, many basic models, while some users, often those with specialised needs, may have wheelchairs custom-built. The usual size of the rear wheel ranges from twenty to twenty-six inches in diameter. A larger wheel increases the height of the seat off the ground and decreases the rolling resistance, thus easing the effort of pushing. The rear wheels can be solid or pneumatic. Solid wheels have a low rolling resistance and are very easy to maintain. They are ideal for use in institutional settings or for indoor use in noncarpeted areas. Pneumatic wheels have better grip on carpeted surfaces and are better if there is going to be significant outdoor use, but they run the risk of flats and require higher maintenance. The flat tire problem can be circumvented by the use of a foam insert that can prevent leaks. Wire spokes are lighter in weight but higher in maintenance. Most older persons will select large plastic spokes referred to as mag wheels. The wheels can be offset posteriorly to decrease the risk of tipping backwards. Wheelchair With 4 Small Wheels: Wheelchair With 4 Small Wheels foldable frame wheelchair made of chrome with 18" inches seat width, 8" Inches Front and Rear wheel, total weight 14 kg helps physical challenged person to move around indoor. Wheelchair With 4 Small Wheels Measurements: Seat Width : 16 inch., 18 inch. Frame Style : Foldable Frame Material : M.S. Chrome open position wheel to wheel width in : 22" (inches) Seat Width : 1